ARVN — Arvinas Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Arvinas Inc

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company develops proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$8.84
Market Cap$587M
Float56.0M
Shares Outstanding64.5M
P/E (Forward)17.86
Price/Sales (TTM)6.57
vs. Analyst Target+69.7% to analyst PT
Profit Margin-247.54%
Operating Margin (TTM)-405.13%
Revenue (TTM)$89.4M
Dividend RateNone
Analyst Target Price$15.00 (21 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $21.8M -$112M $21.8M -$121M
2021 $46.7M -$183M $46.7M -$189M
2022 $131M -$272M $131M -$255M
2023 $78.5M -$367M $78.5M -$395M
2024 $263M -$199M $263M -$244M
2025 $263M -$80.8M $257M -$75.3M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $22.4M -$61.2M
Sep 2025 $41.9M -$35.1M
Dec 2025 $9.5M -$67.4M
Mar 2026 $15.6M -$57.6M

Ownership & Float

Insider Ownership7.8%
Institutional Ownership83.0%
Short Float7.9%
% of All Funds Holding2.25%
Number of Funds Holding185

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$10.08Near-term / short-term trend
Weekly40-Week SMA$10.79Medium-term trend
Weekly80-Week SMA$11.63Cyclical trend (business cycle)
Weekly200-Week SMA$23.89Secular trend (multi-year)
Monthly10-Month SMA$10.68Near-term monthly trend
Monthly20-Month SMA$12.65Medium-term monthly trend
Monthly40-Month SMA$20.86Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$8.60 support 1.27x 6 months ago
$7.10 support 1.99x 12 months ago
$17.70 resistance 3.22x 13 months ago
$26.00 resistance 1.38x 16 months ago
$33.40 resistance 1.38x 22 months ago

Historical Earnings Reactions (32 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 1.10% 0.51% 59.38% 9.27% -2.55%
1 Day 1.80% 1.48% 62.50% 18.67% -7.20%
1 Week 2.74% -0.46% 46.88% 30.07% -12.34%
2 Weeks 1.79% -2.78% 43.75% 53.54% -18.91%
1 Month 3.13% -3.87% 41.94% 89.99% -50.79%

Next earnings: July 31, 2026 (63 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan3.8%50.0%8
Feb0.9%50.0%8
Mar-18.9%12.5%8
Apr7.6%50.0%8
May-13.2%42.9%7
Jun1.3%85.7%7
Jul11.0%71.4%7
Aug-6.0%28.6%7
Sep-7.4%28.6%7
Oct0.8%50.0%8
Nov17.1%75.0%8
Dec34.9%50.0%8

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.00% 47.4% 361
Tuesday 0.02% 46.9% 397
Wednesday 0.33% 53.2% 393
Thursday -0.18% 44.4% 385
Friday 0.25% 50.1% 387

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 83.0%

Insider Transactions — Smart Summary

Total insider ownership: 7.8%

12-Month Insider Activity Summary

Total Filings21
Net Value-$951,694.405
Net Shares Change-76,267
% of Float-0.1%
C-Suite Filings18
Clusters Detected2

Key Insiders

NameTitleNet ValueFilingsActivity
Morrison Briggs +$495,080 2 2 buy
Saik Andrew Chief Financial Officer -$154,069.699 2 1 sell
Cacace Angela M Chief Scientific Officer -$115,312.142 2 1 sell
Berkowitz Noah Chief Medical Officer -$110,384.639 1 N/A
Teel Randy President and CEO -$95,965.472 1 N/A
Loomis David K Chief Accounting Officer -$21,344.571 2 1 sell

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2026-02-18 – 2026-03-02 9 6 -$829,378.54 8 C-suite
2026-05-13 – 2026-05-22 6 5 -$452,039.781 6 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-03-09 Morrison Briggs +$268,070 Transaction at $13.40, now -34.0%
2025-09-24 Morrison Briggs +$227,010 Transaction at $7.57, now +16.8%
2025-06-24 Saik Andrew Chief Financial Officer -$43,377 Transaction at $7.61, now +16.2%
2025-11-07 Loomis David K Chief Accounting Officer -$2,274.7 Transaction at $9.89, now -10.6%
2025-06-18 Cacace Angela M Chief Scientific Officer -$19,346.67 Transaction at $7.49, now +18.0%
2026-05-13 Saik Andrew Chief Financial Officer -$110,692.699 Transaction at $9.94, now -11.0%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Arvinas Inc (ARVN) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for ARVN on Trend Edge →